S&P 500   3,852.28
DOW   31,187.35
QQQ   323.44
S&P 500   3,852.28
DOW   31,187.35
QQQ   323.44
S&P 500   3,852.28
DOW   31,187.35
QQQ   323.44
S&P 500   3,852.28
DOW   31,187.35
QQQ   323.44
Log in

Scythian Biosciences Stock Forecast, Price & News

-0.22 (-5.93 %)
(As of 07/25/2018)
Today's Range
Now: C$3.49
50-Day Range
MA: C$3.49
52-Week Range
Now: C$3.49
Volume703,164 shs
Average Volume231,491 shs
Market CapitalizationC$102.38 million
P/E RatioN/A
Dividend YieldN/A
Scythian Biosciences Corp. engages in the research and development of cannabinoid-based combination drug therapies for the treatment of concussions and traumatic brain injury. It also develops drug candidates for the treatment of gastro-intestinal inflammatory issues. The company is headquartered in Toronto, Canada.


Overall MarketRank

0.52 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual SalesN/A



Market CapC$102.38 million
Next Earnings DateN/A
OptionableNot Optionable
-0.22 (-5.93 %)
(As of 07/25/2018)
30 days | 90 days | 365 days | Advanced Chart

Receive SCYB News and Ratings via Email

Sign-up to receive the latest news and ratings for SCYB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Scythian Biosciences (CVE:SCYB) Frequently Asked Questions

What stocks does MarketBeat like better than Scythian Biosciences?

Wall Street analysts have given Scythian Biosciences a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Scythian Biosciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Scythian Biosciences' key competitors?

What other stocks do shareholders of Scythian Biosciences own?

Who are Scythian Biosciences' key executives?

Scythian Biosciences' management team includes the following people:
  • Mr. Rob Reid, CEO & Director
  • Mr. Jonathan James Held, Chief Financial Officer (Age 32)
  • Mr. Maghsoud Dariani, Chief Scientific Officer (Age 65)
  • Prof. Michael Barnes, Chief Medical Officer

What is Scythian Biosciences' stock symbol?

Scythian Biosciences trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SCYB."

How do I buy shares of Scythian Biosciences?

Shares of SCYB and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Scythian Biosciences' stock price today?

One share of SCYB stock can currently be purchased for approximately C$3.49.

How big of a company is Scythian Biosciences?

Scythian Biosciences has a market capitalization of C$102.38 million.

What is Scythian Biosciences' official website?

The official website for Scythian Biosciences is scythianbio.com.

How can I contact Scythian Biosciences?

Scythian Biosciences' mailing address is 366 Bay St Suite 200, TORONTO, ON M5H 4B2, Canada. The company can be reached via phone at +1-416-3669192.

This page was last updated on 1/20/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.